Sartorius Stedim Biotech Updates on Share and Voting Structures

Sartorius Stedim Biotech S.A., based in Aubagne, France, announced a key update regarding its share and voting rights structure. As of September 30, 2025, the company's issued capital consists of 97,330,405 shares. The total number of theoretical voting rights, including treasury shares, is reported as 165,543,792. Net voting rights, which exclude treasury shares, amount to 165,492,389. This disclosure is made in compliance with Article L 233-8-II of the French Code of Commerce and Article 223-6 of the AMF's general regulations. The information is essential for investors tracking the voting power and ownership interests within the firm.